On the other hand, in a cohort of TTR wild-type cardiomyopathy patients, the p.Gly26Ser polymorphism was found in 7% of subjects and 12% of healthy controls [32], prompting the authors to discuss the genetic variant as a protective factor. Here, TTR is linked to cardiomyopathy.